These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 29407676)

  • 21. In Vivo and Cellular Trafficking of Acetalated Dextran Microparticles for Delivery of a Host-Directed Therapy for Salmonella enterica Serovar Typhi Infection.
    Johnson MM; Collier MA; Hoang KV; Pino EN; Graham-Gurysh EG; Gallovic MD; Zahid MSH; Chen N; Schlesinger L; Gunn JS; Bachelder EM; Ainslie KM
    Mol Pharm; 2018 Nov; 15(11):5336-5348. PubMed ID: 30296381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogen-mimicking vaccine delivery system designed with a bioactive polymer (inulin acetate) for robust humoral and cellular immune responses.
    Kumar S; Kesharwani SS; Kuppast B; Bakkari MA; Tummala H
    J Control Release; 2017 Sep; 261():263-274. PubMed ID: 28669593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual dye in-vivo imaging of differentially charged PLGA carriers reveals antigen-depot effect, leading to improved immune responses in preclinical models.
    Riehl M; Harms M; Lucas H; Ebensen T; Guzmán CA; Mäder K
    Eur J Pharm Sci; 2018 May; 117():88-97. PubMed ID: 29408551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-injecting, bioinspired nanocomposite hydrogel that can recruit host immune cells in situ to elicit potent and long-lasting humoral immune responses.
    Korupalli C; Pan WY; Yeh CY; Chen PM; Mi FL; Tsai HW; Chang Y; Wei HJ; Sung HW
    Biomaterials; 2019 Sep; 216():119268. PubMed ID: 31226570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a biodegradable microparticulate polymer as a carrier for Burkholderia pseudomallei subunit vaccines in a mouse model of melioidosis.
    Schully KL; Bell MG; Prouty AM; Gallovic MD; Gautam S; Peine KJ; Sharma S; Bachelder EM; Pesce JT; Elberson MA; Ainslie KM; Keane-Myers A
    Int J Pharm; 2015 Nov; 495(2):849-61. PubMed ID: 26428631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein corona-mediated targeting of nanocarriers to B cells allows redirection of allergic immune responses.
    Shen L; Tenzer S; Storck W; Hobernik D; Raker VK; Fischer K; Decker S; Dzionek A; Krauthäuser S; Diken M; Nikolaev A; Maxeiner J; Schuster P; Kappel C; Verschoor A; Schild H; Grabbe S; Bros M
    J Allergy Clin Immunol; 2018 Nov; 142(5):1558-1570. PubMed ID: 29382591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient delivery of the toll-like receptor agonists polyinosinic:polycytidylic acid and CpG to macrophages by acetalated dextran microparticles.
    Peine KJ; Bachelder EM; Vangundy Z; Papenfuss T; Brackman DJ; Gallovic MD; Schully K; Pesce J; Keane-Myers A; Ainslie KM
    Mol Pharm; 2013 Aug; 10(8):2849-57. PubMed ID: 23768126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vinyl Sulfone-functionalized Acetalated Dextran Microparticles as a Subunit Broadly Acting Influenza Vaccine.
    Batty CJ; Lifshits LM; Hendy DA; Eckshtain-Levi M; Ontiveros-Padilla LA; Carlock MA; Ross TM; Bachelder EM; Ainslie KM
    AAPS J; 2023 Jan; 25(1):22. PubMed ID: 36720729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of a CD8+ cytotoxic T lymphocyte response to soluble antigen given together with a novel muramyl dipeptide adjuvant, N-acetyl-D-glucosaminyl-(beta 1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine (GMDP).
    Hornung RL; Longo DL; Gowda VL; Kwak LW
    Ther Immunol; 1995 Feb; 2(1):7-14. PubMed ID: 7553072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Merozoite surface protein 2 adsorbed onto acetalated dextran microparticles for malaria vaccination.
    Stiepel RT; Batty CJ; MacRaild CA; Norton RS; Bachelder E; Ainslie KM
    Int J Pharm; 2021 Jan; 593():120168. PubMed ID: 33309558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: adjuvant- and site-dependent immunogenicity in mice.
    Bal SM; Slütter B; Verheul R; Bouwstra JA; Jiskoot W
    Eur J Pharm Sci; 2012 Mar; 45(4):475-81. PubMed ID: 22009113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intradermal vaccination with hollow microneedles: A comparative study of various protein antigen and adjuvant encapsulated nanoparticles.
    Du G; Hathout RM; Nasr M; Nejadnik MR; Tu J; Koning RI; Koster AJ; Slütter B; Kros A; Jiskoot W; Bouwstra JA; Mönkäre J
    J Control Release; 2017 Nov; 266():109-118. PubMed ID: 28943194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An aluminum adjuvant-integrated nano-MOF as antigen delivery system to induce strong humoral and cellular immune responses.
    Zhong X; Zhang Y; Tan L; Zheng T; Hou Y; Hong X; Du G; Chen X; Zhang Y; Sun X
    J Control Release; 2019 Apr; 300():81-92. PubMed ID: 30826373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meningococcal PorB induces a robust and diverse antigen specific T cell response as a vaccine adjuvant.
    Mosaheb M; Wetzler LM
    Vaccine; 2018 Nov; 36(50):7689-7699. PubMed ID: 30381152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant activity of peptidoglycan monomer and its metabolic products.
    Halassy B; Krstanović M; Frkanec R; Tomasić J
    Vaccine; 2003 Feb; 21(9-10):971-6. PubMed ID: 12547610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MIS416, a non-toxic microparticle adjuvant derived from Propionibacterium acnes comprising immunostimulatory muramyl dipeptide and bacterial DNA promotes cross-priming and Th1 immunity.
    Girvan RC; Knight DA; O'Loughlin CJ; Hayman CM; Hermans IF; Webster GA
    Vaccine; 2011 Jan; 29(3):545-57. PubMed ID: 21034827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release.
    Ilyinskii PO; Roy CJ; O'Neil CP; Browning EA; Pittet LA; Altreuter DH; Alexis F; Tonti E; Shi J; Basto PA; Iannacone M; Radovic-Moreno AF; Langer RS; Farokhzad OC; von Andrian UH; Johnston LP; Kishimoto TK
    Vaccine; 2014 May; 32(24):2882-95. PubMed ID: 24593999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delivering all in one: Antigen-nanocapsule loaded with dual adjuvant yields superadditive effects by DC-directed T cell stimulation.
    Paßlick D; Piradashvili K; Bamberger D; Li M; Jiang S; Strand D; R Wich P; Landfester K; Bros M; Grabbe S; Mailänder V
    J Control Release; 2018 Nov; 289():23-34. PubMed ID: 30219277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens.
    Swaminathan G; Thoryk EA; Cox KS; Meschino S; Dubey SA; Vora KA; Celano R; Gindy M; Casimiro DR; Bett AJ
    Vaccine; 2016 Jan; 34(1):110-9. PubMed ID: 26555351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative study of the effects of peptidoglycan monomer and structurally related adamantyltripeptides on humoral immune response to ovalbumin in the mouse.
    Tomasić J; Hanzl-Dujmović I; Spoljar B; Vranesić B; Santak M; Jovicić A
    Vaccine; 2000 Jan; 18(13):1236-43. PubMed ID: 10649625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.